-
IMPROVING OUTCOMES RESEARCH IN PSORIASIS CARE USING REAL-WORLD DATA: APPLICATION OF NATURAL LANGUAGE PROCESSING TO ASSESS AFFECTED BODY AREAS
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN CLINICAL MANIFESTATIONS OF GOUT AND PATIENT REPORTED OUTCOME MEASURES: RESULTS OF A REAL-WORLD SURVEY IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
EVALUATING THE PATIENT BURDEN ASSOCIATED WITH DELAYED REIMBURSEMENT: A CASE STUDY OF PEMBROLIZUMAB IN THE TREATMENT OF ENDOMETRIAL CANCER IN CANADA
Feb 25, 2026, 14:41 PM -
FROM TOKYO TO WASHINGTON: IMPACT OF JAPAN’S HTA ENVIRONMENT ON U.S. MFN PRICING AND LAUNCH STRATEGY
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN TOBACCO SMOKING AND COVID-19 OUTCOMES: A RETROSPECTIVE COHORT STUDY
Feb 25, 2026, 14:41 PM -
SHAME, EMBARRASSMENT, AND THREATS TO DATA VALIDITY DUE TO CONFUSING COA WORDING: EXPLORATION OF CONCEPTUAL OVERLAP IN CRITICAL COA TERMINOLOGY IN THE CONTEXT OF GLOBAL ADMINISTRATION - FROM THE LINGUISTS’ PERSPECTIVE
Feb 25, 2026, 14:41 PM -
HEOR IN THE ABSENCE OF A CODE-BASED POPULATION DEFINITION
Feb 25, 2026, 14:41 PM -
PATIENT-REPORTED OUTCOMES-BASED SYMPTOM MONITORING AMONG PATIENTS RECEIVING IMMUNOTHERAPY FOR LUNG CANCER: A RANDOMIZED CONTROLLED TRIAL
Feb 25, 2026, 14:41 PM -
HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH AML TREATED WITH POST-TRANSPLANT MAINTENANCE THERAPY
Feb 25, 2026, 14:41 PM -
DEVELOPMENT OF A PROFESSIONAL FRAMEWORK FOR MARKET ACCESS WITHIN THE PHARMACEUTICAL INDUSTRY: A MULTI-METHODS STUDY
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL CONTRACEPTIVE IMPLANT (ESI) IN BRAZIL
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL AMONG INDIVIDUALS RECEIVING FIRST-LINE TREATMENT FOR BRCA WILD-TYPE ADVANCED EPITHELIAL OVARIAN CANCER: A PATIENT-LEVEL ANALYSIS OF POOLED HISTORICAL CLINICAL TRIALS
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF RECOMBINANT HUMAN C1 ESTERASE INHIBITOR (RHC1-INH) VS SEBETRALSTAT FOR THE TREATMENT OF SEVERE OR VERY SEVERE HEREDITARY ANGIOEDEMA (HAE) ATTACKS
Feb 25, 2026, 14:41 PM -
PATIENT DESCRIPTIONS OF THE BENEFITS OF A REDUCED CORNSTARCH DOSE REGIMEN IN A PHASE 3 TRIAL OF DTX401 FOR GLYCOGEN STORAGE DISEASE TYPE IA
Feb 25, 2026, 14:41 PM -
A COMPREHENSIVE EVALUATION OF EMPIRICAL ANTIBIOTIC THERAPY, DE-ESCALATION PRACTICES, AND ANTIMICROBIAL RESISTANCE TRENDS IN HOSPITALIZED PATIENTS: A HOSPITAL-BASED OBSERVATIONAL STUDY
Feb 25, 2026, 14:41 PM -
CLINICAL SIGNIFICANCE OF AVAILABLE DRUG INFORMATION RESOURCES REGARDING DRUG-DRUG INTERACTIONS: AN AUDIT FROM A TERTIARY CARE CANCER CENTRE IN INDIA
Feb 25, 2026, 14:41 PM -
IDENTIFYING MIGRAINE IN PRIMARY CARE WORKFLOWS: PREVALENCE, RISK SIGNALS, AND PREDICTIVE TOOLS
Feb 25, 2026, 14:41 PM -
A TOTAL COST OF CARE (TCOC) MODELING TOOL TO EVALUATE SECOND-LINE TREATMENT COSTS FOR PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
Feb 25, 2026, 14:41 PM -
RISING LEVELS OF INNOVATION IN EXPEDITED DESIGNATIONS AMONG FDA-APPROVED DRUGS: 2012-2024
Feb 25, 2026, 14:41 PM -
IDENTIFYING (DIS-)AGREEMENT BETWEEN MODELS FOR EVALUATION OF EFFECTIVENESS OF RISK MINIMIZATION MEASURES (RMMS)
Feb 25, 2026, 14:41 PM
